Variability in the use of intravenous thrombolysis for mild stroke: Experience across the SPOTRIAS network

Journal of Stroke and Cerebrovascular Diseases

Volumn 22, Issue 4, 2013, Pages 318-322

  Willey, Joshua Z ^a   Khatri, Pooja ^b   Khoury, Jane C ^g   Merino, José G ^h   Ford, Andria L ^c   Rost, Natalia S ⁱ   Gonzales, Nicole R ^d   Ali, Latisha K ^e   Meyer, Brett C ^f   Broderick, Joseph P ^b  

^a Department of Neurology Columbia University ^*  (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^h NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Mild stroke; stenosis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; DRUG USE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; CLINICAL TRIAL; EPIDEMIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PRACTICE GUIDELINE; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; STROKE; TIME; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL; VERY ELDERLY;

ACADEMIC MEDICAL CENTERS; ADMINISTRATION, INTRAVENOUS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; FEMALE; FIBRINOLYTIC AGENTS; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

EID: 84877068195     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2011.09.005     Document Type: Article

References (19)

1. Tissue plasminogen activator for acute ischemic stroke The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 1995 1581 1587
2. H.C. Schumacher, B.T. Bateman, and B. Boden-Albala Use of thrombolysis in acute ischemic stroke: Analysis of the Nationwide Inpatient Sample 1999 to 2004 Ann Emerg Med 50 2007 99 107
3. K.Z. Bambauer, S.C. Johnston, and D.E. Bambauer Reasons why few patients with acute stroke receive tissue plasminogen activator Arch Neurol 63 2006 661 664
4. D. Kleindorfer, B. Kissela, and A. Schneider Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: A population-based study Stroke 35 2004 e27 e29
5. Recombinant tissue plasminogen activator for minor strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience Ann Emerg Med 46 2005 243 252
6. H. Adams, R. Adams, and G. Del Zoppo Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association Stroke 36 2005 916 923
7. H.P. Adams Jr., R.J. Adams, and T. Brott Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association Stroke 34 2003 1056 1083
8. D. Cocho, R. Belvis, and J. Marti-Fabregas Reasons for exclusion from thrombolytic therapy following acute ischemic stroke Neurology 64 2005 719 720
9. K. Nedeltchev, B. Schwegler, and T. Haefeli Outcome of stroke with mild or rapidly improving symptoms Stroke 38 2007 2531 2535
10. V. Rajajee, C. Kidwell, and S. Starkman Early MRI and outcomes of untreated patients with mild or improving ischemic stroke Neurology 67 2006 980 984
11. E.E. Smith, A.R. Abdullah, and I. Petkovska Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke Stroke 36 2005 2497 2499
12. P.A. Barber, J. Zhang, and A.M. Demchuk Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility Neurology 56 2001 1015 1020
13. P.M. Bath, R.H. Martin, and Y. Palesch Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: A PRoFESS subgroup analysis Stroke 40 2009 3541 3546
14. U. Fischer, A. Baumgartner, and M. Arnold What is a minor stroke? Stroke 41 2010 661 666
15. D.F. Edwards, M. Hahn, and C. Baum The impact of mild stroke on meaningful activity and life satisfaction J Stroke Cerebrovasc Dis 15 2006 151 157
16. S.B. Coutts, C. O'Reilly, and M.D. Hill Computed tomography and computed tomography angiography findings predict functional impairment in patients with minor stroke and transient ischaemic attack Int J Stroke 4 2009 448 453
17. N.K. Hills, and S.C. Johnston Why are eligible thrombolysis candidates left untreated? Am J Prev Med 31 6 Suppl. 2 2006 S210 S216
18. J.S. van den Berg, and G. de Jong Why ischemic stroke patients do not receive thrombolytic treatment: Results from a general hospital Acta Neurol Scand 120 2009 157 160
19. P. Khatri, D.O. Kleindorfer, and S.D. Yeatts Strokes with minor symptoms: An exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials Stroke 41 2010 2581 2586